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ABSTRACT
Pertussis is an acute and very contagious pulmonary disease, clinically characterized by periods of coughing and 
paroxysms that may cause death. The disease afflicts mainly the pediatric population and is life threatening to children 
under the age of 1 year. Since the beginning of the second millennium, the number of cases of pertussis has increased, 
menacing public health, despite the availability of the pertussis vaccine. The resurgence of the disease among adults 
and older children creates a reservoir of infection that will afflict the unimmunized or incompletely immunized children. 
As newborns and infants show the highest mortality rate, immunization during pregnancy is a new strategy to reduce 
the burden of pertussis. The authors report the case of a newborn that presented respiratory distress accompanied by 
marked leukocytosis. Bronchiolitis was the initial diagnostic hypothesis, but the clinical picture became typical of pertussis 
when paroxysmal coughing ensued. Isolation of the Bordetella pertussis and antigenic demonstration by polymerase chain 
reaction were positive from respiratory secretion. Despite appropriate antibiotic therapy and intensive care management 
the child died and the autopsy showed characteristic diagnostic findings. The authors call attention to this diagnosis when 
facing respiratory failure among young children, mainly in the presence of marked leukocytosis. Thorough research on 
the immunization status of the patient’s social environment is of crucial importance.
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CASE REPORT
A 16-day-old male newborn was brought to the 
emergency facility with a 3-day history of respiratory 
distress and cough without fever. He was born at 
38 weeks of gestational age, through vaginal delivery 
with an Apgar score of 9,10,10 at 1,5 and 10 minutes, 
respectively, weighing 2700 g and 47 cm long. 
The mother was gesta 4 and para 4, aged 23 years and 
went through an uneventful prenatal period, which 
comprised seven medical consultations. The newborn 
was discharged 2 days after birth and was healthy and 
exclusively breastfed.
On physical examination, the patient presented 
signs of respiratory insufficiency with room air oximetry 
of 86% and the presence of bilateral pulmonary rales. 
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His initial chest radiography showed superior right lobe 
atelectasis (Figure 1).
Bronchiolitis was diagnosed at first glance, and 
therefore he was hospitalized in the neonatal intensive 
care unit (NICU) to receive oxygen and enteral feeding.
The clinical outcome was troublesome initially 
requiring non-invasive respiratory support and 
subsequently orotracheal intubation, and mechanical 
ventilation coupled with intravenous fentanyl infusion. 
Pulmonary imaging sequences showed atelectasis of 
the left upper lobe and signs of bilateral hyperinflation. 
At this time, nasopharyngeal secretion was collected 
for Bordetella pertussis research, and azithromycin 
was started, since the patient had begun paroxysmal 
coughing.
On the seventh day of hospital izat ion, a 
marked leukocytosis (leukocytes = 92,200/mm3 with 
1% promyelocytes, 1% myelocytes, 1% metamyelocytes, 
8% band cells, 36% neutrophils, 40% lymphocytes, 
12% monocytes, 14% eosinophils, with normal platelets 
and red blood cell count) and C-reactive protein = 73 mg/L 
(reference value [RV]: < 5 mg/dL) were observed. 
The chest radiography was repeated and showed bilateral 
cardiac silhouette blurring besides opacities in the upper 
two-thirds of the right lung and in the medial third of the 
left lung, which motivated the association of amikacin 
and oxacillin to the previous antibiotic regimen (Figure 2). 
The outcome was unfavorable and hemodynamic 
instability ensued requiring dobutamine and nitric oxide 
administration. Unfortunately all efforts were insufficient 
and the patient died on the seventh day of hospitalization. 
The polymerase chain reaction (PCR) and nasopharynx 
culture for B. pertussis were both positive, which were 
available post mortem.
AUTOPSY FINDINGS
After the opening of cavities, mild bilateral pleural 
effusion was drained. The lungs were heavy (right 
lung weighed 54.0 g [RV: 31.0 g]; left lung weighed 
42.0 g [RV: 27.0 g]) covered by glossy, smooth pleura 
with patchy purple areas. The cut surface showed a 
firm-consistency pulmonary parenchyma with glossy 
and purple surface, which is consistent with shock lung 
(Figure 3).
The microscopic examination disclosed extensive 
diffuse alveolar damaged areas intermingled with edema, 
Figure 1. Plain chest radiography showing opacity in the 
upper half of the right lung, delimited by the horizontal 
fissure, which is upwardly displaced and associated with 
hyperinflation of the remaining right lung and the entire 
left lung with deviation of the trachea to the right. The 
findings consistent with right upper lobe atelectasis.
Figure 2. Plain chest radiography showing bilateral 
perihilar opacities predominantly of an alveolar pattern 
with air bronchogram, partially blurring the cardiac 
silhouette and mediastinum, giving the appearance of 
a fuzzy heart.
alveolar hemorrhage, and pneumonia. Necrotizing 
bronchiolitis, characterized by respiratory epithelium 
necrosis, intraluminal desquamated epithelium, cellular 
debris, and fibrin were also observed. Interlobular septa 
were slightly thickened by acute inflammatory infiltration 
and dilated lymphatic vessels with leukostasis (Figure 4).
Gram-negative bacilli colonies, identified by 
Brown-Hopps staining, were found within some alveoli 
and bronchiole’s respiratory epithelium (Figure 5).
The heart weighed 18.8 g (RV: 20.0 g) and still 
presented patency of the oval foramen, probably 
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Figure 3. Gross view of the enlarged right lung. A - Glossy pleura and purple patchy areas. B - The cut surface with 
condensed parenchyma intermingled with purple-colored areas.
Figure 4. Photomicrography of the lung. A - Exudative phase of the diffuse alveolar damage with alveolar spaces filled 
by macrophages, cellular debris and fibrin (H&E, 100X). B - Pneumonia. Note the alveolar spaces filled by numerous 
neutrophils (H&E, 200X). C - Lymphatic vessel in the interlobular septum containing leukostasis. Note pulmonary 
edema in the adjacent pulmonary parenchyma (H&E, 100X). D - Focal necrotizing bronchiolitis with necrosis of the 
epithelial lining and intraluminal fibrin and cellular debris (H&E, 200X).
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Figure 5. Photomicrography of the lung. A - Bacterial colonies within the alveolar lumen (H&E, 400X). B - Gram-negative 
bacilli within the alveolar lumen (arrow) (Brown-Hopps, 1000X). C and D – Bacilli rod-shaped bacteria associated with 
the ciliary respiratory epithelium of the bronchiole (arrows) (Brown-Hopps, 1000X).
due to pulmonary hypertension related to the acute 
pulmonary disease.
The l iver was enlarged (weighed 159.0 g 
[RV: 127 g]) and showed purple parenchyma at the cut 
surface. At microscopy, signs of passive congestion with 
extensive sinusoidal dilatation were present besides the 
presence of grade-2 microvesicular steatosis and remnant 
extramedullary hematopoiesis. The spleen weighed 
10.1 g (RV: 12 g) and showed red pulp congestion and 
white pulp lymphocyte depletion (Figure 6).
DISCUSSION
Pertussis, also called whooping cough, is an acute 
and very contagious pulmonary disease, with typical 
manifestation characterized by periods of cough and 
paroxysms. The etiologic agent is a small, aerobic 
Gram-negative bacillus, pathogenic only in humans. 
The transmission is made through the inhalation of 
respiratory fluids from ill contacts. Symptoms usually 
develop 5–10 days after contact with the diseased 
(not exceeding 3 weeks).1,2
Worldwide, an estimated 50 million cases of 
pertussis take place every year, accompanied by up to 
300,000 deaths. During the 1990s, a marked reduction 
in the incidence was observed, due to the expansion of 
an efficient immunization policy. However, since 2011, 
an increasing number of cases have been observed, 
affecting mostly children in their first year of age. 
In 2010, a pertussis outbreak hit California, USA, 
with more than 9000 reported cases and 10 reported 
infant deaths.3 Such an increase in the incidence of this 
disease was also seen in Australia, The Netherlands, 
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Canada, Belgium, Germany, UK, and Japan at the 
same time.4 Since 2011 in Brazil, and in the state of 
São Paulo, there has been a progressive increase in the 
incidence of pertussis despite the universal coverage 
of immunization. In Brazil in 2008, the incidence was 
0.71 cases/100,000 inhabitants; however, in 2014, the 
incidence increased to 37 cases/100,000 inhabitants 
with nearly 50 cases/100,000 inhabitants in the state 
of São Paulo—the highest rate compared with other 
Brazilian states. The mortality rate of pertussis in 
Brazil increased from 0.7% (23 deaths) in the 1990s 
to 1.7% (109 deaths) in 2013.5-8 The reasons for 
the re-emergence of the disease are still unknown, 
but among the possibilities that some researchers 
believe, is a cyclical behavior with a re-appearance 
every 4–5 years, while others believe in bacterial 
antigenic changes. Recent studies showed a difference 
in the virulence factors of both the circulating and 
the vaccine strains of B. pertussis, suggesting an 
imposed selection pressure on the bacterial strains 
circulating in the population caused by vaccination. It 
is also believed that the shift from whole cell pertussis 
vaccine (DTwP) to acellular pertussis vaccine (DTaP) led 
to a rise in pertussis cases. DTaP replaced the DTwP in 
most countries during the 1990s, when the disease 
became more frequent. DTaP is supposed to produce 
short-lived immunity, which means that adolescents 
and adults would not be protected from B. pertussis. 
Other theories include improved reporting of cases 
secondary to increased awareness, the use of PCR 
assays for diagnosis, and pockets of populations with 
high rates of vaccination refusal.3,4,9-10.
Figure 6. A - Photomicrography of the liver showing zone three sinusoidal dilatations due to passive congestion 
(H&E, 100X). B – Photomicrography of the liver with extramedullary hematopoiesis. Note the megakaryocyte within 
the hepatic sinusoid (arrow) (H&E, 200X). C and D - Photomicrography of the spleen showing red pulp congestion 
and white pulp lymphocytary depletion (arrow) (H&E, 100X).
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The clinical manifestation of pertussis depends 
on the patients’ age, any previous immunization or 
infection, co-infection with other respiratory infectious 
agents, the presence of passively acquired antibodies, 
and perhaps other factors related to the host and 
organism, such as virulence. The disease is usually 
characterized by three distinct stages. The first one is 
called the catarrhal stage, which takes 1–2 weeks and 
is marked by mild respiratory symptoms (low fever, 
runny nose, and malaise), progressing towards 
whooping cough. The second stage, called paroxysmal, 
has the duration of 2–6 weeks and is characterized by 
episodes of paroxysmal coughing and high-pitched 
whoop, which may be accompanied by cyanosis and 
vomiting. This phase evolves to the convalescent stage, 
when the patient remains with a persistent cough with 
no paroxysms for about 2–6 weeks.2,11
Whooping cough can be severe and life-threatening 
in young children, particularly in children younger than 
6 months, and in not fully immunized individuals. 
Fifty percent of children younger than 1 year old with 
pertussis are hospitalized and subject to a diverse 
range of complications. Apnea is the commonest 
complication in around 60% of hospitalized children 
under 12 months old, followed by pneumonia, 
seizures, encephalopathy, and death due to cough or 
toxins. Infants under the age of the first vaccination 
dose are substantially prone to a fatal outcome.12-14
Fulminant pertussis, is another clinical presentation 
of whooping cough, which is defined by a rapidly 
evolving combination of pneumonia, cardiopulmonary 
failure, neurologic involvement, and severe pulmonary 
hypertension, which quite frequently leads to death.12 
Such a presentation is more common in infants 
younger than 1 year old, who usually acquire the 
infection from housemate adults with an incomplete 
vaccination calendar. The most accepted pathogenetic 
hypothesis for this form of pertussis relies on the 
direct pulmonary damage caused by B. pertussis 
toxins coupled with the hyperviscosity syndrome 
due to the peripheral leukocytosis, pulmonary 
hypertension due to the presence of widespread 
leukocyte thrombi throughout the pulmonary vascular 
bed, and consequent hypoxia.15,16 Our case was 
characterized by severe respiratory insufficiency, 
pulmonary hypertension and marked leukocytosis.
Paddock et al.16 studied respiratory tissue specimens 
of 15 autopsy cases of fulminant pertussis in infants aged 
younger than 4 months. The main histopathological 
findings were tracheitis, bronchitis and necrotizing 
bronchiolitis, alveolar edema and hemorrhage, 
diffuse alveolar damage, neutrophilic pneumonia, 
interlobular septal edema, and angiolymphatic 
leukocyte aggregates. Clusters of Gram-negative 
coccobacilli were also identified within the bronchiolar 
epithelia and in alveolar lumens. Another retrospective 
study of 10 autopsy cases also described lymphocytic 
depletion in lymph nodes, thymus, and spleen. 
Other findings included hepatic congestion and fatty 
changes, as well as acute tubular necrosis.17 According 
to Paddock et al.,16 B. pertussis pneumonia may 
trigger a cascade of events that includes hypoxia, 
acidosis, and acute pulmonary vasoconstriction, which, 
combined with pertussis toxin-mediated leukocytosis, 
contributes to the restriction of pulmonary blood 
flow. These compounded effects produce marked 
pressure elevation in the vasculature of the infant lung 
that exacerbates hypoxemia and ultimately causes 
cardiac failure, shock, and acute respiratory distress.16 
The autopsy findings of our case are in concordance 
with the literature, thence representing a typical case 
of fulminant pertussis.
The Center of Disease Control defines a case of 
pertussis when the patient presents a cough for 2 or 
more weeks associated with one of the following 
symptoms: paroxysms of coughing, inspiratory whoop, 
post-tussive vomiting, or apnea (with or without 
cyanosis—for infants aged < 1 year). The final diagnosis 
is made with the isolation of B. pertussis in culture from 
nasopharyngeal specimens or with the PCR positivity 
from respiratory secretion. Marked leukocytosis with 
lymphocytosis (especially during the paroxysmal stage) 
is another laboratorial finding in the presence of a 
radiological image of pneumonia. The average count 
of leukocytes can reach 30,000–40,000 with 60–80% 
of lymphocytes.3,14 Marked leukocytosis (white blood 
counts > 100,000/mm3) in patients aged younger 
than 2 months represents a poor outcome predictor.15 
Despite the typical pattern on presentation and the 
laboratory studies, pertussis is under-recognized in 
intensive care, with only 28% of the cases being 
suspected when admitted in the pediatric intensive 
care unit (PICU).18
The antibiotic therapy, involving the macrolides 
(mainly azithromycin) or trimethopim-sulfamethoxazole 
in case of intolerance, can reduce the intensity of 
the symptoms and the illness duration.13 In cases of 
fulminant disease due to hyperviscosity syndrome 
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(due to leukocytosis), treatment modalities that 
reduce the number of leukocytes, such as exchange 
transfusion or leukapheresis, may be associated 
with a better outcome. Extracorporeal membrane 
oxygenation can be used as a treatment for pulmonary 
hypertension and hyperviscosity syndrome; however, 
discouraging outcomes have been reported.15,19
The primary prophylaxis is made with the 
administration of vaccine against the B. pertussis, 
which is already included in the Brazilian public 
immunization calendar. Usually, the basic immunization 
against pertussis includes three doses of the vaccine 
in the first year of life, followed by a fourth dose 
during the preschool years.20 The vaccine has efficacy 
of around 75–80%, but the protection declines over 
the years. Following the policy adopted in the USA14, 
in 2014, the Brazilian Health Ministry also advocated 
the vaccination of all pregnant women after 27 weeks 
of gestational age with DtaP (diphtheria, tetanus and 
pertussis) vaccine.21 This policy foresees a reduction in 
the incidence of the disease among children younger 
than 1 year of age, especially those under 6 months, 
due to the vertical immunization.22
Physicians should be aware of this re-emerging 
disease, mainly when faced with very young children 
with respiratory symptoms. Survival may be dependent 
on the earliest and adequate therapeutic management. 
An effective immunization program is of paramount 
importance to reduce the incidence and severity of 
this disease.
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